Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $141334.0.

  • Lipocine's Cash from Financing Activities changed N/A to $141334.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $358774.0, marking a year-over-year increase of 7583.43%. This contributed to the annual value of $209340.0 for FY2024, which is 4825.58% down from last year.
  • As of Q3 2025, Lipocine's Cash from Financing Activities stood at $141334.0.
  • Over the past 5 years, Lipocine's Cash from Financing Activities peaked at $29.4 million during Q1 2021, and registered a low of -$1.5 million during Q2 2022.
  • In the last 5 years, Lipocine's Cash from Financing Activities had a median value of -$5900.0 in 2022 and averaged $1.7 million.
  • In the last 5 years, Lipocine's Cash from Financing Activities plummeted by 11840.66% in 2021 and then soared by 95690454.55% in 2023.
  • Over the past 5 years, Lipocine's Cash from Financing Activities (Quarter) stood at -$838463.0 in 2021, then soared by 99.3% to -$5900.0 in 2022, then increased by 10.19% to -$5299.0 in 2023, then skyrocketed by 4203.42% to $217440.0 in 2024, then crashed by 35.0% to $141334.0 in 2025.
  • Its last three reported values are $141334.0 in Q3 2025, $217440.0 for Q2 2024, and -$8100.0 during Q1 2024.